Short answer · Medically reviewed summary · Last updated: 2026-05-08
Uterine Carcinosarcoma, also known as Malignant Mixed Müllerian Tumor (MMMT), is a rare and aggressive form of uterine cancer officially classified as a metaplastic carcinoma. Medical terminology for this condition has evolved significantly, leading to multiple synonyms found in older literature and international medical records. What are the common synonyms for Uterine Carcinosarcoma? Because the understanding of this disease has shifted from viewing it as a "sarcoma" to recognizing its nature as a high-grade carcinoma, you may encounter various labels.
Uterine Carcinosarcoma (MMMT) synonyms
Other names for Uterine Carcinosarcoma (MMMT): synonyms, acronyms and related terms used by doctors and patients.
Uterine Carcinosarcoma, also known as Malignant Mixed Müllerian Tumor (MMMT), is a rare and aggressive form of uterine cancer officially classified as a metaplastic carcinoma. Medical terminology for this condition has evolved significantly, leading to multiple synonyms found in older literature and international medical records.
What are the common synonyms for Uterine Carcinosarcoma?
Because the understanding of this disease has shifted from viewing it as a "sarcoma" to recognizing its nature as a high-grade carcinoma, you may encounter various labels. The most frequent synonyms and historical terms include:
- Malignant Mixed Müllerian Tumor (MMMT): The most common historical term still frequently used in clinical settings.
- Mixed Mesodermal Tumor: An older term referring to the embryological origin of the tissue.
- Carcinosarcoma of the Uterus: The currently preferred terminology in modern pathology.
- Malignant Mixed Mesodermal Tumor: A term sometimes seen in older international oncology journals.
Why are there so many names for this condition?
The nomenclature for Uterine Carcinosarcoma has changed due to advancements in molecular pathology. Historically, because the tumor contains both carcinomatous (epithelial) and sarcomatous (mesenchymal) components, it was classified as a sarcoma. Modern research, however, proves that Uterine Carcinosarcoma is actually a monoclonal neoplasm—a carcinoma that has undergone metaplastic transformation. This reclassification explains why clinicians today prefer the term Uterine Carcinosarcoma over the older "MMMT" designation.
How is this disease classified in medical systems?
Standardized classification systems help ensure consistency for the 31 members of the DiseaseMaps.org community and patients worldwide. In the ICD-O (International Classification of Diseases for Oncology), Uterine Carcinosarcoma is often coded under morphology code 8950/3. Orphanet classifies it as a rare gynecological tumor, and it is widely recognized by the World Health Organization (WHO) classification of tumors of the female reproductive organs.
Next steps
- Consult a gynecologic oncologist to confirm the specific pathology report terminology.
- Request your medical records to clarify if your diagnosis is listed as Uterine Carcinosarcoma or MMMT for insurance and treatment planning.
- Connect with the 31 community members on DiseaseMaps.org to share experiences regarding diagnosis and treatment pathways.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider.
References
- Orphanet: Rare Disease Database (ORPHA:99948)
- NIH Genetic and Rare Diseases Information Center (GARD)
- World Health Organization (WHO) Classification of Tumours: Female Genital Tumours
- National Cancer Institute (NCI) PDQ Cancer Information Summary
